header

2013

Bottcher T, Rolfs A, Tanislav C, Bitsch A, Kohler W, Gaedeke J, Giese AK, Kolodny EH, Duning T (2013) Fabry disease - underestimated in the differential diagnosis of multiple sclerosis? PLoS One 8: e71894.

Bottcher T, Rolfs A, Meyer B, Grossmann A, Berg D, Kropp P, Benecke R, Walter U (2013) Clinical, genetic, and brain sonographic features related to Parkinson's disease in Gaucher disease. J Neurol 260: 2523-2531.

Eisenloffel C, Schmole AC, Pews-Davtyan A, Brennfuhrer A, Kuznetsov SA, Hubner R, Frech S, Schult C, Junghanss C, Beller M, Rolfs A, Frech MJ (2013) Interference of a novel indolylmaleimide with microtubules induces mitotic arrest and apoptosis in human progenitor and cancer cells. Biochem Pharmacol 85: 763-771.

Fazekas F, Enzinger C, Schmidt R, Dichgans M, Gaertner B, Jungehulsing GJ, Hennerici MG, Heuschmann P, Holzhausen M, Kaps M, Kessler C, Martus P, Putaala J, Ropele S, Tanislav C, Tatlisumak T, Norrving B, Rolfs A (2013) MRI in acute cerebral ischemia of the young: the Stroke in Young Fabry Patients (sifap1) Study. Neurology 81: 1914-1921.

Hovakimyan M, Meyer A, Lukas J, Luo J, Gudziol V, Hummel T, Rolfs A, Wree A, Witt M (2013) Olfactory deficits in Niemann-Pick type C1 (NPC1) disease. PLoS One 8: e82216.

Hovakimyan M, Maass F, Petersen J, Holzmann C, Witt M, Lukas J, Frech MJ, Hubner R, Rolfs A, Wree A (2013) Combined therapy with cyclodextrin/allopregnanolone and miglustat improves motor but not cognitive functions in Niemann-Pick Type C1 mice. Neuroscience 252: 201-211.

Kropp P, Holzhausen M, Kolodny E, Becker U, Dichgans M, Diez-Tejedor E, Enzinger C, Fazekas F, Fuentes B, Karpinska A, Meyer W, Tanislav C, Bottcher T, Rolfs A (2013) Headache as a symptom at stroke onset in 4,431 young ischaemic stroke patients. Results from the "Stroke in Young Fabry Patients (SIFAP1) study". J Neural Transm 120: 1433-1440.

Lukas J, Giese AK, Markoff A, Grittner U, Kolodny E, Mascher H, Lackner KJ, Meyer W, Wree P, Saviouk V, Rolfs A (2013) Functional characterisation of alpha-galactosidase a mutations as a basis for a new classification system in fabry disease. PLoS Genet 9: e1003632.

Morgan PJ, Hubner R, Rolfs A, Frech MJ (2013) Spontaneous calcium transients in human neural progenitor cells mediated by transient receptor potential channels. Stem Cells Dev 22: 2477-2486.

Rolfs A, Giese AK, Grittner U, Mascher D, Elstein D, Zimran A, Bottcher T, Lukas J, Hubner R, Golnitz U, Rohle A, Dudesek A, Meyer W, Wittstock M, Mascher H (2013) Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients. PLoS One 8: e79732.

Rolfs A, Fazekas F, Grittner U, Dichgans M, Martus P, Holzhausen M, Bottcher T, Heuschmann PU, Tatlisumak T, Tanislav C, Jungehulsing GJ, Giese AK, Putaala J, Huber R, Bodechtel U, Lichy C, Enzinger C, Schmidt R, Hennerici MG, Kaps M, Kessler C, Lackner K, Paschke E, Meyer W, Mascher H, Riess O, Kolodny E, Norrving B (2013) Acute cerebrovascular disease in the young: the Stroke in Young Fabry Patients study. Stroke 44: 340-349.

Schmole AC, Hubner R, Beller M, Rolfs A, Frech MJ (2013) Small molecules in stem cell research. Curr Pharm Biotechnol 14: 36-45.

Trilck M, Hubner R, Seibler P, Klein C, Rolfs A, Frech MJ (2013) Niemann-Pick type C1 patient-specific induced pluripotent stem cells display disease specific hallmarks. Orphanet J Rare Dis 8: 144.

Lin J, Yan X, Wang C, Talabattula VA, Guo Z, Rolfs A, Luo J. Expression patterns of the ADAMs in early developing chicken cochlea. Dev Growth Differ. 2013. 55: 368-76.